NCTId,final_date,start_date,field_changed,final_value,start_value
NCT06925269,2025-04-21 07:12:40.937900,,New  Study  Added,,
NCT01247207,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-03-11,2025-03-25
NCT01247207,2025-04-21 07:12:40.937900,2025-04-14 07:12:54.615614,Last Update Post Date,2025-04-17,2025-03-11
NCT01633866,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2024-12-16,2025-03-25
NCT01999075,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Results First Post Date,2025-01-09,2025-03-25
NCT01999075,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-01-09,2025-03-25
NCT02069756,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-02-10,2025-03-25
NCT02369731,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-03-14,2025-03-25
NCT02413450,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-01-31,2025-03-25
NCT02470962,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-03-20,2025-03-25
NCT02485938,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Results First Post Date,2025-01-09,2025-03-25
NCT02485938,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-01-09,2025-03-25
NCT02500381,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2024-12-16,2025-03-25
NCT03333590,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-03-13,2025-03-25
NCT03340675,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-02-12,2025-03-25
NCT03362502,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-02-21,2025-03-25
NCT03368742,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-02-06,2025-03-25
NCT03368742,2025-04-21 07:12:40.937900,2025-04-14 07:12:54.615614,Brief Summary,"This is a controlled, open-label, single-ascending dose study to evaluate the safety, tolerability and efficacy of SGT-001 in adolescents and children with Duchenne muscular dystrophy (DMD). Participants will receive a single intravenous (IV) infusion of SGT-001 and will be followed for approximately 5 years.
The protocol was amended to drop the control arm after 4 participants were dosed. Participants currently enrolling are assigned to active treatment. Control participants enrolled under original protocol will continue through the study per the original protocol.","This is a controlled, open-label, single-ascending dose study to evaluate the safety, tolerability and efficacy of SGT-001 in adolescents and children with Duchenne muscular dystrophy (DMD). Patients will receive a single intravenous (IV) infusion of SGT-001 and will be followed for approximately 5 years.
The protocol was amended to drop the control arm after 4 subjects were dosed. Subjects currently enrolling are assigned to active treatment. Control subjects enrolled under original protocol will continue through the study per the original protocol."
NCT03368742,2025-04-21 07:12:40.937900,2025-04-14 07:12:54.615614,Primary Outcome Measure,Primary safety endpoint,"Primary efficacy endpoint, Primary safety endpoint, Primary safety endpoint, Primary safety endpoint, Primary safety endpoint, Primary safety endpoint"
NCT03368742,2025-04-21 07:12:40.937900,2025-04-14 07:12:54.615614,Primary Completion Date,2026-10-15,2022-10-17
NCT03368742,2025-04-21 07:12:40.937900,2025-04-14 07:12:54.615614,Last Update Post Date,2025-04-16,2025-02-06
NCT03406780,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Results First Post Date,2025-02-24,2025-03-25
NCT03406780,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-02-24,2025-03-25
NCT03655223,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Secondary Id,HHSN27500003,"U01TR001792-01, HHSN27500003"
NCT03655223,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Primary Completion Date,2025-11-30,2024-11-30
NCT03655223,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-04-04,2024-03-27
NCT03836300,2025-04-14 07:12:54.615614,2025-04-07 07:13:06.388759,Primary Completion Date,2026-06-30,2024-12-31
NCT03836300,2025-04-14 07:12:54.615614,2025-04-07 07:13:06.388759,Completion Date,2026-12-31,2025-06-30
NCT03836300,2025-04-14 07:12:54.615614,2025-04-07 07:13:06.388759,Last Update Post Date,2025-04-06,2024-05-01
NCT03863119,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-02-10,2025-03-25
NCT03947112,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-03-05,2025-03-25
NCT03963453,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-03-05,2025-03-25
NCT03992430,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2024-12-20,2025-03-25
NCT04004065,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-03-10,2025-03-25
NCT04281485,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-01-13,2025-03-25
NCT04322357,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-02-27,2025-03-25
NCT04428476,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Results First Post Date,2025-02-24,2025-03-25
NCT04428476,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-02-24,2025-03-25
NCT04529707,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-03-07,2025-03-25
NCT04906460,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-02-19,2025-03-25
NCT05126758,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-02-04,2025-03-25
NCT05166109,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2024-12-27,2025-03-25
NCT05195775,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-02-27,2025-03-25
NCT05257473,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-03-10,2025-03-25
NCT05257473,2025-04-14 07:12:54.615614,2025-04-07 07:13:06.388759,Overall Status,Active Not Recruiting,Recruiting
NCT05257473,2025-04-14 07:12:54.615614,2025-04-07 07:13:06.388759,Primary Completion Date,2026-05-01,2025-05-01
NCT05257473,2025-04-14 07:12:54.615614,2025-04-07 07:13:06.388759,Last Update Post Date,2025-04-06,2025-03-10
NCT05291091,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-04-03,2025-03-25
NCT05412394,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-02-13,2025-03-25
NCT05429372,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-03-04,2025-03-25
NCT05429372,2025-04-21 07:12:40.937900,2025-04-14 07:12:54.615614,Primary Completion Date,2025-06-30,2025-05-30
NCT05429372,2025-04-21 07:12:40.937900,2025-04-14 07:12:54.615614,Completion Date,2025-06-30,2029-01-03
NCT05429372,2025-04-21 07:12:40.937900,2025-04-14 07:12:54.615614,Last Update Post Date,2025-04-18,2025-03-04
NCT05524883,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-01-22,2025-03-25
NCT05540860,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2024-12-27,2025-03-25
NCT05558813,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-02-03,2025-03-25
NCT05670730,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-03-11,2025-03-25
NCT05683379,2025-04-14 07:12:54.615614,2025-04-07 07:13:06.388759,Primary Completion Date,2026-09-01,2024-12-01
NCT05683379,2025-04-14 07:12:54.615614,2025-04-07 07:13:06.388759,Completion Date,2026-09-01,2024-12-01
NCT05683379,2025-04-14 07:12:54.615614,2025-04-07 07:13:06.388759,Last Update Post Date,2025-04-06,2024-07-18
NCT05689164,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-02-07,2025-03-25
NCT05689164,2025-04-21 07:12:40.937900,2025-04-14 07:12:54.615614,Enrollment Count,6.0,5.0
NCT05689164,2025-04-21 07:12:40.937900,2025-04-14 07:12:54.615614,Primary Completion Date,2025-08-29,2039-05-15
NCT05689164,2025-04-21 07:12:40.937900,2025-04-14 07:12:54.615614,Completion Date,2025-08-29,2039-05-15
NCT05689164,2025-04-21 07:12:40.937900,2025-04-14 07:12:54.615614,Last Update Post Date,2025-04-18,2025-02-07
NCT05693142,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-03-12,2025-03-25
NCT05849688,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Overall Status,Unknown,Not Yet Recruiting
NCT05881408,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-02-17,2025-03-25
NCT05881408,2025-04-21 07:12:40.937900,2025-04-14 07:12:54.615614,Last Update Post Date,2025-04-15,2025-02-17
NCT05938023,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-02-03,2025-03-25
NCT05967351,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-01-17,2025-03-25
NCT05982119,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-02-12,2025-03-25
NCT06053814,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2024-12-17,2025-03-25
NCT06054971,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-03-21,2025-03-25
NCT06066580,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-03-11,2025-03-25
NCT06079736,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-03-04,2025-03-25
NCT06128564,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-03-17,2025-03-25
NCT06128564,2025-04-21 07:12:40.937900,2025-04-14 07:12:54.615614,Last Update Post Date,2025-04-13,2025-03-17
NCT06138639,2025-04-21 07:12:40.937900,2025-04-14 07:12:54.615614,Last Update Post Date,2025-04-15,2025-03-26
NCT06224660,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-02-27,2025-03-25
NCT06241950,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-03-03,2025-03-25
NCT06244082,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-02-07,2025-03-25
NCT06363526,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Brief Title,Effectiveness of 5-week Digital Respiratory Practice in Children With Duchenne and Becker Muscular Dystrophies.,Effectiveness of 5-week Digital Respiratory Practice in Children With Duchenne Muscular Dystrophy and Becker Muscular Dystrophy.
NCT06363526,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Secondary Outcome Measure,"Perform an anthropometric study of the patient's characteristics, taking into account weight; and also a general physical examination., Perform an anthropometric study of the patient's characteristics, taking into account age., Perform an anthropometric study of the patient's characteristics, taking into account height., Perform an anthropometric study of the patient's characteristics, taking into account sex., Examine changes in forced expiratory pressure, Analyze changes in maximum inspiratory pressure (MIP) and maximum expiratory pressure (MEP)., Check if there are changes in the sniff nasal inspiratory pressure (SNIP), Evaluate the fatigue in patients using an EPInfant test., Evaluate the quality of life of patients using a scale called ""Kindscreen-52""., North Star Ambulatory Assessment o NSAA","Perform an anthropometric study of the patient's characteristics, taking into account weight; and also a general physical examination., Perform an anthropometric study of the patient's characteristics, taking into account age., Perform an anthropometric study of the patient's characteristics, taking into account height., Perform an anthropometric study of the patient's characteristics, taking into account sex., Examine changes in forced expiratory pressure, Analyze changes in maximum inspiratory pressure (MIP) and maximum expiratory pressure (MEP)., Check if there are changes in the sniff nasal inspiratory pressure (SNIP), Evaluate the fatigue in patients using an EPInfant test., Evaluate the quality of life of patients using a scale called ""Kindscreen-52""., NSAA o North Star Ambulatory Assessment"
NCT06363526,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-04-01,2025-03-26
NCT06402942,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-03-12,2025-03-25
NCT06445985,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-01-30,2025-03-25
NCT06450639,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-03-07,2025-03-25
NCT06450639,2025-04-14 07:12:54.615614,2025-04-07 07:13:06.388759,Start Date,2025-04-04,2025-03-31
NCT06450639,2025-04-14 07:12:54.615614,2025-04-07 07:13:06.388759,Last Update Post Date,2025-04-08,2025-03-07
NCT06564974,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Brief Title,Registry Study to Observe Long-term Safety of Vamorolone (AGAMREE®) in Patients With Duchenne Muscular Dystrophy.,Registry Study to Observe Long-term Safety of Vamorolone (AGAMREE®) in Patients with Duchenne Muscular Dystrophy.
NCT06564974,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-04-02,2025-03-25
NCT06597656,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-03-03,2025-03-25
NCT06692426,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-03-24,2025-03-25
NCT06755138,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Study First Post Date,2025-01-01,2025-03-25
NCT06755138,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-01-01,2025-03-25
NCT06756633,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Study First Post Date,2025-01-03,2025-03-25
NCT06756633,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-01-03,2025-03-25
NCT06769633,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Study First Post Date,2025-01-10,2025-03-25
NCT06769633,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-01-24,2025-03-25
NCT06773988,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Study First Post Date,2025-01-14,2025-03-25
NCT06773988,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-01-14,2025-03-25
NCT06817382,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Study First Post Date,2025-02-10,2025-03-25
NCT06817382,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-02-10,2025-03-25
NCT06817382,2025-04-14 07:12:54.615614,2025-04-07 07:13:06.388759,Overall Status,Recruiting,Not Yet Recruiting
NCT06817382,2025-04-14 07:12:54.615614,2025-04-07 07:13:06.388759,Start Date,2025-05-31,2025-02-07
NCT06817382,2025-04-14 07:12:54.615614,2025-04-07 07:13:06.388759,Last Update Post Date,2025-04-11,2025-02-10
NCT06833489,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Study First Post Date,2025-02-18,2025-03-25
NCT06833489,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-02-18,2025-03-25
NCT06833931,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Study First Post Date,2025-02-19,2025-03-25
NCT06833931,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-03-18,2025-03-25
NCT06839469,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Study First Post Date,2025-02-21,2025-03-25
NCT06839469,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-02-21,2025-03-25
NCT06861270,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Study First Post Date,2025-03-06,2025-03-25
NCT06861270,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-03-06,2025-03-25
NCT06867107,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Study First Post Date,2025-03-10,2025-03-25
NCT06867107,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-03-10,2025-03-25
NCT06868784,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Study First Post Date,2025-03-11,2025-03-25
NCT06868784,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-03-17,2025-03-25
NCT06874166,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Study First Post Date,2025-03-13,2025-03-25
NCT06874166,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-03-13,2025-03-25
NCT06887491,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Study First Post Date,2025-03-20,2025-03-25
NCT06887491,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-03-20,2025-03-25
NCT06900049,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Brief Title,"Evaluation of the Safety, Tolerability, and Efficacy of LE051 in Patients With Duchenne Muscular Dystrophy","Evaluation of the Safety, Tolerability, and Efficacy of LE051 in Patients with Duchenne Muscular Dystrophy"
NCT06900049,2025-04-07 07:13:06.388759,2025-03-31 07:12:50.276131,Last Update Post Date,2025-04-02,2025-03-28
